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Abstract: The aim of the study was to determine the time of mineral growth in human spine 
ligaments using a mathematical model. The study was based on our previous research in which the 
physicochemical analysis and computed microtomography measurements of deposits in ligamenta 
flava were performed. Hydroxyapatite-like mineral (HAP) constituted the mineral phase in ligament 
samples, in two samples calcium pyrophosphate dehydrate (CPPD) was confirmed. The micro-damage 
of collagen fibrils in the soft tissue is the crystallization center. The growth of the mineral nucleus 
is a result of the calcium ions deposition on the nucleus surface. Considering the calcium ions, 
the main component of HAP, it is possible to describe the grain growth using a diffusion model. 
The model calculations showed that the growth time of CPPD grains was ca. a month to 6 years, 
and for HAP grains >4 years for the young and >5.5 years for the elderly patients. The growth time of 
minerals with a radius >400 pm was relatively short and impossible to identify by medical imaging 
techniques. The change of growth rate was the largest for HAP deposits. The mineral growth time 
can provide valuable information for understanding the calcification mechanism, may be helpful in 
future experiments, as well as useful in estimating the time of calcification appearance.
Keywords: calcification; collagen; computed microtomography; mineralization model; hydroxyapatite; 
ligamenta flava
1. Introduction
Mineralization of soft tissues, such as aortic valve cusps, tendons and ligaments, is a progressive 
disorder which has been reported for many years [1,2]. It was considered as a passive process of 
calcium salts deposition in tissues. However, the use of advanced techniques enables a detailed analysis 
of mineralized areas of a tissue [3]. Recent studies have shown some similarities of pathological 
mineralization with actively controlled processes in bones [4- 7]. Bone mineralization is the formation 
of hydroxyapatite on the biological matrix which is of collagen fibrils. Collagen fibrils occurring in 
bones demonstrate specific interfibrillar spaces (structural gaps) endowed with an electric charge where 
the nucleation of bone apatite can be started. Collagen is not a crystallization promoter but the process 
is assisted by matrix vesicles released from the osteoblast cell membrane [8,9]. The matrix vesicles are 
rich in proteins, phospholipids, calcium, and inorganic phosphates and provide the right concentration 
of Ca and P for crystal precipitation. During bone mineralization, collagen fibrils aggregate side by 
side in a lateral register, their gap zones also come to be in the register, and give rise to transverse, 
'electron-dense bands' that cross the collagen bundles [9]. The effect of such fibril aggregation is the 
creation of electrically charged areas in which the hydroxyapatite crystals are formed. The collagen 
fibril aggregation manner reflects a crystal shape. It is known that after the start of nucleation in fibril 
gaps, crystal growth initially takes place within the structural gap and then covers the area outside
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the gap [10]. The similarity of the calcification mechanism in the presented model with physiological 
mineralization relies mainly on the presence of gap zones in collagen fibrils in which the nucleation of 
mineral grains occurs. The authors focused on the physical aspects of the ion deposition process as a 
consequence of the presence of structural micro-damages.
A significant role in pathological tissue calcification is attributed to mechanical stress (accumulation 
of microtrauma). The experimental studies performed on the spines of rats demonstrated that stretching 
and torsion movements result in the proliferation of cartilage tissue, transforming into bone tissue in 
the spinal ligaments [11,12]. Similarly, studies performed on patients exposed to stretching showed an 
increase in the; rate of cytokines associated with the bone formation process (i.e., bone morphogenic 
protein, BMP) [^ 1 2 ].
The influence of pathological spine curvatures, especially thoracic kyphosis, on the mineral 
deposits formed in spine ligaments has been confirmed. Abnormal spine curvature leads to changes in 
the strain distribution, especially in the part of the lower flooracic spine where the calcitication of the 
ligaments is most frequent [13]. Structural micro-damage as a result of microtrauma of the tissue can 
be a place of mineral nucleation.
It has betn  suggested that ligament mineralization may b e th e  cause of canal stenosis or vice 
versa— it is the result of degenerative changes [7,f4 ] . Spinal sienosis is a condition in which there 
is a disproportion between the volume of fhe canal and the volume of the spinal cord, leading to 
compression of the spinal roots. As a resulf of the spinal canal narrowing, the spinal ligaments bend, 
which undergohypertrophy and calcification [15]. Many authors have shown that mineralization 
of the spinal ligaments is correlated with spinnd canal stenosis [7,76-1 8 ] . Histological results show 
that the degenerative changes in the spinal ligaments are manifested by a decrease in the amount 
of elastin and an increase in collagen content . Thi s process it explained by defects and mechanical 
stress in the ligaments, resulting in further damnge, and as a result elastin iraementation and collagen 
proliferation [h|.
Yellow ligamenls (iigamenta flava, LF) are structures located between the arches of neighboring 
vertebrae. They close the spinal canal front the back (Figure 1). Due to their elasticity, they are of 
great importance; for ihe ttatics and mechanic ft of the spine, stabilizing the spine in the sagittal plane 
and preventing excessive bending tow trds the front [69]. The non-typical structure of the yellow 
ligaments, consisting of a collagen to eltstin  ratio iff 1:12, is a reason for a significtnt adaptation to 
mechanical loads, especially to strelching: This may explain the sltght and mcidental mineralization of 
LF. The prevention of soft tisrue calc ification is d ifticult because the presence of mineral deposits in 
the early stage of growih often does not give dlntcal symptoms. Described pathology is diagnosed in 
an advanced stage as accompanying other disea s e t  Therefore, the growth tim e of mineral deposits 
in soft tissues is difficult to estimate. The mineralization of the ligamenta flava in an advanced stage 
can cause neurological disturbsnces rince the mineralized ligament can comprers the spinal cord. 
The most typical symptoms are pain, reduced musde strength with paresis, disturbances of feeling in 
the perianal region, as well as loss of control over micturition and defecation [20].
Figure 1. Ligament system stabilizing the spine.
The m echanism  of m ineralization in tissues is described in the literature using several 
models [21- 27]. However, the time of mineral growth in human soft tissues has not been discussed.
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According to Urry's charge neutralization theory of calcification, calcium is bound to neutral sites of 
protein and phosphate while carbonate ion binding follows to produce charge balance. A circular 
dichroism pattern of solutions of organic acids demonstrates that calcium ions reverse conformational 
changes in the molecular structure. Neutral bonding sites on uncharged polypeptides bind cations by 
coordination with acyl oxygens and change the electrochemical properties of collagen. Binding of Ca 
ions is a chronic progressive process with age [28,29].
The aim of the study was to determine the time of mineral growth based on a diffusion model. 
The knowledge about the growth time of minerals in the yellow ligaments as we ll as in the case of 
other soft tissues lias fundamental importance, giving information on tine calcification mechanism. 
It supports the estimation of a relation between incidents in the human body (i.e., metal:)olism disease, 
stenosis of tissues, change of diet, and mechanical trauma related to sport), as well as the appearance 
of calcifications. Thanks to this; knowledge the elimination or reduction of harmful factors is feasible. 
It should be strensed that the important advantage of the demonstrated model is ehe calculation based 
on the analysis of human samples using our experimental data [30] concerning the mineralization in 
human ligamenta flava. The models generally presented in ihe literature are based m ainly on the 
analysis of lab oratory animal subjects (rats, mice) which are characterized by faster metabolism than 
the metabolism in the human case. The use of large animals as models of calcification has still been 
discussed [21,31-3 3] .
2. M aterials and M ethod 3
The 24 ligamentum flavum samples (LF), surgically extracted from the lumbar spine at the level of 
L1-L5 vertebrae, were analyzed. The bio logical material consisted of 15 samples of ligaments obtained 
from patients, aged (55-81) years old, qualifying for surgery due to spinal canal stenosis. The control 
group contained 9 samples of ligaments taken from patients aged 20-53 years old who had undergone 
m echanical spinal trauma. The physicochemical analysis of mineral cteposits in LF was performed 
in our previous work [30] with the use of Fourier transform inerased spectroscopy (FTIR) and X-ray 
fluorescence (XRF) techniques. Moreover, the volume send density of mineral grains were calculated 
using computed microtomography (p-CT) [30] . The obtained data were pul; to uie in model calculations. 
The reconstructed p-CT image of the ligamentum flavum with mineral deposits is shown is in Figure 2. 
The analysis was carried out for two chemical structures of deposits: hydroxyapatite-like minerals 
(HAP) and calcium pyrophosphate dehydrate (CPPD) in ligaments of elderly patients suffering from 
canal spinal stenosis and the young patients from the control group.
Figure 2. The reconstructed p-CT image of the yellow ligament (stenotic group) with two threshold 
values. The upper threshold value (gray) refers to the soft tissue, the lower value (black) is mineral grain. 
Measurement with a resolution of 13.5 pm. The area measured with a resolution of 2 pm is marked. 
A two-dimensional cross-section of this area with the thresholding described above is shown [30].
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2.1. Assumptions and Calculations
The micro-damage of the collagen fibril is the center of tire mineral grain crystallization. The; growth 
of the mineral nucleus, located in the extracellular fluid environment, occurs aa a result of calcium 
ions deposition on the nucleus surlaco. TOe elemehtal analysis of deposits performed in aur previous 
work [° 0] confirmed that Ca was present in thahighest concentration in the minerals.
Considaring the caiciom ions, which art the main component of the minarai phase in deposits, 
it is possible to deecribe the p rocess of grgin growth using a diffusion mo del. The proposed model wil 1 
enable us to estimete the growth time of the mineral grains. The following assumptioos were made:
1. .A spherical symmetry of the system,
2. The transport of calcium iono is the limiting factor for grain growth,
3. 1STo chemical reactions in the environment
Due to spherical symmetry, the ion flow J  depends only on the distance r between the center of
the system (sphere) and the selected point in space (Figure 3).
Figure 3. Schematic representation of grain growth with radius r.
According to the law of mass conservation, the number of ions entering the spherical space 
with the radius r is equal to the number of ions adsorbed on the surface of the nucleus, therefore we 
can varite:
-  4nr2J(r) +  4n(r +  dr)2 * J (r  +  dr) =  0
In the Equation (1) the formula J(r + dr) was developed into the Taylor series: 
-  4nr2J(r) +  4n(r2 +  2rdr +  (dr)2) * |J(r) +  “^ dr) =  0
(1)
(2 )
Ultimately, the differential Equation (2) takes the form:
(3)
Integration of Equation (3) leads to the dependence of the ionic flux from the distance r from the 
center of the system:
J = % , (4)v 2
where Ci is an integration constant. According to Fick's first law, an ion flux can be written as:
j=-4 (5)
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where D is the diffusion coefficient, c is the concentration of calcium ions. Comparing Equations (4) 
and (5) and integrating we obtain a solution in the Equation (6):
c(r) =  D r +  C 2 (6)
The calculation of the integration constants Ci and C2 requires the assumption of boundary 
conditions. It was assumed that for r ^  ra the ion concentration is equal to Co, while on the grain 
surface with the radius r the concentration is zero.
c(ra) =  Co
c(r) =  0
The application of the above boundary conditions allows the determination of the integration
constants Ci and C2 expressed by Equations (7) and (8).
Ci =  -CoD * r (7)
C2 =  co (8)
Thus, the ionic flux on the nucleus surface with the radius a, can be expressed by the Equation (9):
j  =  - D —  =  D * Co
dr r= a a
(9)
Thus, the total ion flux on the nucleus surface is:
I  =  4naDc0 (10)
Assuming that the grain density is equal to p, we can use the expression describing the mass 
increase of grain in time, which is equal to the total ion flux I  on the nucleus surface, according to 
Equation (10). Therefore, the increase in the mass of grain over time is expressed by the Equation (11) as:
d  ( 3 na3p) = 4na2p d = 4nDa * c0 (11)
Assuming that at the initial moment t = 0, the grain radius is equal to 0, the solution of the 
Equation (12) is:
a2 * p
t =  2DrP ~  (12)2D * C0
Based on the growth time, it is possible to determine the rate of grain growth by the Equation (13):
da -  A  - 1 (13)dt yft a
2.2. Data Used in Calculations
Based on the calculations, the analysis of the change in the grain radius over time was carried out. 
The following literature data were used in the calculations:
-Diffusion constant for calcium ions in muscle tissue: D = 1.65 X 10-6 (cm2/s) [34],
-The concentration of uncomplexed calcium: C0 = 42 mg/l = 4.2 X 10-5 (g/cm3), which is 50% of 
the total calcium in extracellular fluids [35].
The value of radius (a) and density (p) of grains come from experimental data from our previous 
work [30]. The density of CPPD and HAP grains with a radius of a = (0.02-0.1) cm in LF samples,
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extracted from the young patients and the elderly patients with stenosis, is presented in Table 1. 
The histogram of minerals density distribution in LF is presented in Figure 4 .
Table 1. The range of density (p) of calcium pyrophosphate dehydrate (CPPD) hydroxyapatite-like 
mineral (HAP) grains with a radius of a = (0.02-0.1) cm from control and stenosis groups of patients.
Age (Years) Density (g/cm3)
c p i5:) 72 2.15-2.25
CPPD 81 2.61-2.40
HAP control 35 1.78-1.95
HAp control 36 1.85-2.0
HAP stenosis 59 1.85-2.0
HAP stenosis 60 1.87-2.20
Figure 4. Histogram of grains density distribution (p) in ligamentum flavum samples. C—percentage 
contribution of minerals with given density in 100 mm3 of a sample [30].
3. Results
The examples of results of the model calculations, which show a dependence of the grain radius 
from the minerals growth time built with CPPD, are presented in Figure 5. The dependence of a(t) for
HAP minerals in ligaments from the control group (35 and 36 y.o.) and the stenotic group (59 and
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60 y.o.) are shown in Figures 6 and 7, respectively. The differences between individual cases were 
insignificant, therefore the most diverse examplee are presented. The maximum mfaeurement error, 
shown in Figures 5-7 , -was half of the voxel size. For the remeining cases, mecsurement errors did not 
differ significantly. The calculations assume that the values of D and C0 are constant for all cases.
Figure 15. The dependence of the radius value of mineral grains built Uroem calcium pyrophosphate 
dehydrate iCPPD) fromthe growth time for two cases of yellow iigaments.
Figure 6. The dependence of the radius value of1 mineral grains built from HAP foom the growth time 
for Owo cases o0 the yellow ligamenUs young patients (control group).
Figure 7. The dependence of the radius value of mineral grains built from hydroxyapatite-like mineral 
(HAP) from the growth time for two cases of the yellow ligaments of elderly patients (stenosis group).
In Figure 5 it can be seen that the growth time of CPPD grains ranged from ca. a month to 6 years, 
while in the case of HAP grains (Figure 6, Figure 7) it was up to 4 years for the young and up to
5.5 years for the elderly patients. The results of da/dt calculations for CPPD and HAP grains are shown 
in Table 2.
Table 2. da/dt for the minimum and maximum radius (a) of CPPD and HAP grains for selected cases 
of age.
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Age (Years) A = 0.02 cm A = 0.1 cm
CPPD 72 1.75 X  10-9 cm/s 2.9 X  10-10 cm/s
CPPD 81 1.54 X  10-9 cm/s 3.0 X  10-10 cm/s
HAP-control 35 1.89 X  10-9 cm/s 4.78 X  10-10 cm/s
HAP-control 36 1.78 X  10-9 cm/s 3.7 X  10-10 cm/s
HAP-stenosis 59 1.76 X  10-9 cm/s 3.56 X  10-10 cm/s
HAP-stenosis 60 1.0 X  10-9 cm/s 3.2 X  10-10 cm/s
4. Discussion
A model of collagen mineralization was presented to estimate the growth time of mineral grains. 
The complexity of the system required a few simplifications. The most important was the assumption 
about the spherical shape of grains and the assumption that the growth environment is built only 
of calcium ions. Nevertheless, it is possible to develop the model with additional factors, as the 
following; a multi-component growth environment, competitiveness of ions between grains, partial 
dissolution of grains, fluctuations of internal environment conditions, adoption of plate or cylindrical 
shape, aggregation of nucleus, Ostwald ripening, etc. In the model calculation the constant diffusion D 
for the muscle tissue was used because of some similarities in the structure of tissues, however the 
difference between the muscle tissue and the ligament may be due to the viscosity of these tissues. 
In Figure 5 it can be seen that the growth time of minerals built of CPPD equals ca. a month to 6 years, 
while for HAP minerals it is up to 4  years for the young patients from the control group and up 
to 5.5 years for the elderly patients from the stenosis group. The value of a/ t decreases with the 
increase of the grain radius. It should be noted that the largest change in a/ t was noticed for deposits 
built of HAP. It suggests that CPPD deposition may differ from HAP and can be controlled by the 
factors involved in rheumatic and metabolic diseases, correlating with overproduction of inorganic 
pyrophosphate [7]. Factors affecting the rate of grain growth include diet, systemic diseases (diabetes, 
obesity), and used drugs that have a direct impact on the composition of physiological fluids and 
calcium metabolism. Some differences in da/dt values for HAP and CPPD may indicate different types 
of crystallite growth. At the same time, there are no significant da/dt differences between young and 
elderly patients, which suggests that the HAP mineralization in both groups of patients follows similar 
mechanisms. The analysis of the volume of the mineral at different time-lapses could provide more 
detailed information about the grain growth and the calcification mechanism. In the human body 
it is extremely difficult to observe the mechanism of mineral growth but an experiment carried out 
in vivo on the animal model or in vitro with the use of p-CT measurements is feasible and awaits 
further investigation.
In the case of the knowledge of calcium density in the individual grains it would be possible to 
calculate the correlation between the calcium flux from the extracellular environment and an increase 
in grain mass in which the major contribution is calcium. However, the physicochemical analysis 
performed in our previous work [30] did not allow the determination of the calcium density in each 
grain. Thanks to the high resolution of p-CT it was possible to calculate the density of the grains, 
built of HAP and CPPD. This approach would be considered in future models of calcification and 
requires the use of high-resolution methods of elemental analysis but needs further investigation.
The experimental data which describe the time of calcification growth in vivo are very sparing 
and relate to animal models. However, the results have been compared with models demonstrated in 
the literature [31,36]. The analysis was performed on mineral deposits culturing in vivo for 10 days. 
It was shown that the growth rate of mineral deposits with a diameter of 0.002 cm, extracted from
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rats, is about 2.1 X 10-9 cm/s [31], whereas for our model calculations the growth rate is equal to 
1.75 X 10-9 cm/s for a = 0.02 cm. The significant difference in deposits size, which grow in a short 
time, unequivocally indicates a faster metabolic rate in animals compared to humans. Arroyo and 
colleagues [37] presented the calcification model in horse arterials. The mineral deposits with a size 
of 5 mm grew in about 4 years. Our results show that within 4 years, the minerals reach ~1.6 mm in 
diameter. The difference in the size of minerals may be due to the faster metabolic rate in horses as 
well as the localization of mineral growth. The rate growth of calcifications in arteries may be intensive 
because of the constant contact with the blood environment.
According to a computational model for aortic heart valve calcification, 25% of the leaflet was 
covered by calcification in about 6 years [36,38]. The computational model confirms our model 
calculations. In the same time of growth, a massive CPPD mineralization in LF was confirmed [30]. 
The analysis carried out on patients in [39] shows that calcifications with a volume of ~2.9 mm3 appears 
after 4.7 ± 0.8 years, which confirms the results of model calculations of mineral grains with a volume 
of ~3.04 mm3 growth for about 5 years.
Calcium metabolism disorder is most often diagnosed in parathyroid and kidney diseases, as well 
as in disorders of vitamin D metabolism [40]. The presence of chronic diseases and the use of drugs that 
affect calcium absorption, as well as individual differences and a change of eating habits, may cause 
a disturbance of the calcium balance. Changes in the ion concentration in physiological fluids may 
affect the size of grains and the growth time that have a promoting or inhibiting effect (Mg2+, Sr2+) 
on the mineralization process [41,42]. It is worth mentioning the inhibitors which play a major role 
in preventing ectopic mineralization. In vitro experiments show that osteocalcin (bone-Gla protein), 
osteonectin, and an elevated rate of osteopontin, induced by hyperphosphatemia, may have an 
inhibitory effect on matrix mineralization by binding to lattice calcium exposed at the crystal surfaces, 
regulating crystal dimensions [43]. The proteoglycans (i.e., decorin, lumican, biglycan) have important 
roles in matrix mineralization and may block active nucleating sites on the HAP surface slowing down 
the growth process [44,45].
Analyzing the decrease in da/dt values of grains with age, several factors that inhibit growth can 
be mentioned. First of all, the fastest growth can take place up to the saturation of all free chemical 
bonds in the micro-damage of the collagen matrix. Then, the grain grows outside the micro-damage. 
If the concentration of ions involved in mineralization remains constant, the invariable number of ions 
is adsorbed on the growing surface of the spherical grain, and thus the increase in grain radius takes 
place in a longer and longer time. The grain growth can also be decreased or inhibited by the change 
of diet or elimination of calcium interfering drugs on the influence on Ca absorption [46].
The second issue may be the partial dissolution of grains for the growth of others, which may also 
dissolve over time. The difference in the growth time of the CPPD and HAP grains suggests that the 
mechanism of mineralization does not follow identical pathways. A reflection of this phenomenon is 
that there are also more than five times a higher number of CPPD grains per 100 mm3 of tissue than in 
the case of HAP grains [23]. Differences in the number and size of grains suggest that they were in a 
different phase of growth, and the nucleation of grains probably occurred at different times. It should 
be mention that the mineral deposits had a heterogeneous structure. Hydroxyapatite was confirmed 
as the main mineral phase. However, chemical analysis confirmed the presence of a small amount 
of hydroxyapatite precursors (octocalcium phosphate and amorphous calcium phosphate) in a few 
cases [30] . The presence of the precursor structures can be included in the calculations for a detailed 
analysis of the growth mechanism.
In the model calculations, the concentration of free calcium ions was used. It should be noted that 
in extracellular fluid about 40% of calcium is bound to proteins, mainly albumin, while ~10% Ca is in 
the form of complexes with organic anions such as citrate and lactate anions. The remaining 50% is 
ionized calcium with high physiological significance. The assumptions adopted in the work do not 
take into account fluctuations in calcium concentration, and the results show the time of the grain 
growth with undisturbed calcium management.
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The presented model is the first step in estimating the growth time of mineral grains in human soft 
tissues. It may be useful in experiments and in analysis of the calcification mechanism. This knowledge 
can be crucial in the elimination or reduction of harmful factors leading to loss of tissue elasticity 
not only in the spine ligaments case but also in stenosis of the aortic valve and cartilage and tendon 
mineralization. The growth rate may give information about the presence of additional factors 
promoting the growth of calcifications. The knowledge about the growth time of minerals in soft 
tissues may aid in estimating a relationship between the incidence in the human body (i.e., metabolism 
disease, stenosis of tissue or mechanical trauma related to sport) and the appearance of calcifications, 
as well as supplying information on the mineralization of breast, prostate, and thyroids, where the 
appearance of mineral grains is very often the first symptom of the tumor process [47- 50].
5. Conclusions
The model results indicate that the growth time of mineral grains with a radius of up to 400 gm 
is relatively short, less than a year, and very difficult or impossible to identify by medical imaging 
techniques, such as magnetic resonance imaging and computed tomography. Larger grains with a 
radius of 1000 gm, visible in medical imaging methods, take about 6 years. Therefore, this pathology is 
only diagnosed at a higher stage as co-accompanying, usually on the occasion of diagnosis of other 
diseases. Some differences in da/dt values for HAP and CPPD suggest different types of crystallite 
growth. It is likely that additional factors are involved in the mechanism of CPPD growth. At the same 
time, there were no significant da/dt differences between the control and stenosis groups, suggesting 
that the HAP mineralization in both groups of patients follows similar mechanisms. It indicates that the 
spinal canal stenosis does not influence the calcification growth rate. Differences in the growth time of 
grains suggest that they were at a different stage of growth, and probably nucleation occurred at other 
times The proposed model can be developed with the use of additional factors, for example other ions 
in the extracellular fluid or fluctuation in ion concentration. Determination of the time of calcification 
growth in the yellow ligaments as well as in the case of other soft tissues has an important role in 
supplying information on the calcification mechanism and the relation between disease incidents 
and the appearance of pathological mineralization. It can support the elimination or reduction of the 
harmful factors that promote mineralization.
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